Leerink Swann Reiterates an 'Outperform' on Cadence Pharma (CADX); View on Ofirmev Markman Hearing and Upcoming Decisions

Go back to Leerink Swann Reiterates an 'Outperform' on Cadence Pharma (CADX); View on Ofirmev Markman Hearing and Upcoming Decisions